dc.contributor.author
Bravo Amaro, Marisol
dc.contributor.author
Sitges Carreño, Marta
dc.contributor.author
Mirabet Pérez, Sonia
dc.contributor.author
Avanzas, Pablo
dc.contributor.author
Mazón, Pilar
dc.contributor.author
De la Torre, José M.
dc.contributor.author
Crespo, Marisa
dc.contributor.author
Sanchis Forés, Juan
dc.contributor.author
Vivas, David
dc.contributor.author
Andrea, Rut
dc.contributor.author
Martínez Momblán, Ma. Antonia
dc.contributor.author
Cordero Fort, Alberto
dc.contributor.author
Torres Llergo, Javier
dc.contributor.author
Jiménez Candil, F. Javier
dc.date.issued
2026-01-20T17:05:12Z
dc.date.issued
2025-11-25
dc.date.issued
2026-01-20T17:05:13Z
dc.date.issued
info:eu-repo/date/embargoEnd/2026-11-24
dc.identifier
https://hdl.handle.net/2445/225854
dc.description.abstract
The 2025 ESC guidelines for the management of cardiovascular disease and pregnancy1 address the need for an updated review of the previous recommendations. A special effort has been made to provide clear information, supported by summary tables, graphical abstracts, and flow charts that enhance clinical applicability. Cardiovascular disease (CVD) is now the leading cause of nonobstetric mortality in pregnant women,2 with a rising incidence of acquired heart disease.
dc.format
application/pdf
dc.publisher
Elsevier España
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.rec.2025.11.004
dc.relation
Revista Española de Cardiología (English Edition), 2025
dc.relation
https://doi.org/10.1016/j.rec.2025.11.004
dc.rights
cc-by-nc-nd (c) Sociedad Española de Cardiología, 2025
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/embargoedAccess
dc.subject
Malalties cardiovasculars
dc.subject
Cardiovascular diseases
dc.title
Insights into the 2025 ESC guidelines for the management of cardiovascular disease and pregnancy
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
